Our aim was to determine the cardiovascular outcome of patients with capillary blood flow (CBF) abnormalities detected during demand stress in the absence of obstructive coronary artery disease.
S
tress echocardiography (SE) has become an integral part of the evaluation of patients with suspected or known coronary artery disease (CAD). 1 Numerous studies have demonstrated that simultaneous assessment of microvascular perfusion and wall motion (WM) is feasible and accurate when incorporated into a clinical SE service. [2] [3] [4] [5] [6] [7] Real-time perfusion echocardiography (RTPE) allows for the simultaneous analysis of capillary blood flow (CBF) 8 and WM during SE, permitting side-by-side comparisons with resting flow and WM. [8] [9] [10] [11] [12] [13] CBF analysis with RTPE improves the sensitivity and accuracy of exercise and dobutamine SE in detecting coronary artery stenosis. 10, 14, 15 The improvement in prognostic value of CBF analysis, when combined with WM assessment, has been demonstrated with both dobutamine and high-dose dipyridamole SE. 14, 16, 17 A consistent observation with any stress perfusion or WM imaging technique is that there are a considerable number of false positives, in which an inducible defect within a given coronary artery territory does not have a significant obstructive lesion detected at subsequent angiography. [18] [19] [20] [21] Because it is assumed that a normal or nonobstructive coronary angiogram identifies a low-risk patient in this setting, high-profile journals have called for better strategies for risk stratification. 22 Although some of these perfusion abnormalities may truly be caused by attenuation or artifacts, a significant number seem as genuine territorial defects that cannot be explained on the basis of these technical limitations. The myocardial contrast intensity obtained during RTPE reflects CBF and volume. Although microvascular disease has frequently been referred to as inducible perfusion abnormalities without epicardial disease at angiography, we now understand that capillaries play a major role in regulating coronary blood flow during hyperemic stress in the presence or absence of a significant epicardial stenosis. The prognosis of a patient who exhibits a genuine inducible microvascular perfusion defect in the absence of obstructive CAD has not been not fully explored. Small-sized patient studies examining demand stress WM responses and radiolabeled tracer uptake have suggested that significant cardiovascular events may still occur in this subpopulation. 1, 17, 18 In the present investigation, we sought to determine whether patients with CBF abnormalities during demand stress, in the absence of angiographic obstructive disease, have a significant cardiovascular event rate. A genuine defect was defined as an inducible defect within a coronary artery territory that is confirmed by 2 independent reviewers and does not meet criteria for attenuation or artifact.
METHODS
The data, analytic methods, and study materials will not be made available to other researchers for purposes of reproducing the results or replicating the procedure. The authors state that this study complies with the Declaration of Helsinki. The institutional review board has approved the research protocol, and informed consent from subjects was waived. Out of a total of 11 693 patients referred for SE during the time period of 2008 through 2013, there were 399 (3.4%) referred for coronary angiography (CA) within 90 days of the dobutamine or exercise SE. These stress studies used RTPE to examine CBF with a continuous infusion of ultrasound contrast [13] [14] [15] as described below. All patients had preserved resting left ventricular systolic function (left ventricular ejection fraction ≥40%). Risk factors considered in the evaluation of patient outcome were age, sex, hypertension, smoking, diabetes mellitus, hyperlipidemia, obesity, and positive family history. Diabetes mellitus was defined according to the requirement for treatment with insulin or oral hypoglycemic agents or according to the definition by the American Diabetes Association. 7 Hypertension was defined as systolic blood pressure ≥140 mm Hg, diastolic blood pressure ≥90 mm Hg, or the use of antihypertensive medication. Hyperlipidemia was defined as total cholesterol 200 mg/dL or therapy with a lipid-lowering agent. History of CAD was defined as prior myocardial infarction (MI) or prior coronary revascularization. Family history of CAD was defined as the premature presence of CAD in any first-degree sibling (men <55 years and women <65 years). Follow-up information was obtained from review of medical records in all patients.
Real-Time Perfusion Echocardiography
The contrast agent used for all studies was the commercially available lipid-encapsulated microbubble Definity (Lantheus Medical Imaging, North Billerica, MA). This agent was administered as a 3% intravenous continuous infusion at 4 to 6
CLINICAL PERSPECTIVE
Abnormal capillary blood flow detected with demand stress perfusion echocardiography has been correlated with abnormal coronary blood flow reserve measured with invasive hemodynamics. In the current study, we demonstrated that patients with abnormal capillary blood flow but normal or nonobstructive angiographic disease had a 2-fold higher likelihood of adverse events at 4-year follow-up period compared with those with negative stress perfusion echocardiography and normal or nonobstructive angiography. These outcome differences persisted even after excluding patients whose deaths were presumably from noncardiac causes. By improving the detection of capillary blood flow abnormalities during demand stress imaging, real-time perfusion echocardiography can better identify a high-risk patient group that should be followed closely irrespective of angiographic findings and prospectively evaluated for new therapeutic strategies.
Kutty et al; Capillary Blood Flow Abnormality in Demand Stress mL/min under resting conditions and during stress. The infusion was adjusted to optimize myocardial opacification while minimizing attenuation from left ventricular cavity contrast. Typically image acquisitions for rest and stress imaging are 2 to 3 minutes, especially during stress acquisitions. So 1 vial was more than adequate to complete the entire study. RTPE was performed with ultrasound scanners equipped with lowmechanical index real-time pulse sequence schemes (Philips iE33, or Siemens Acuson Sequoia). The MI was kept at ≤0.25, and the frame rate was kept at 20 to 25 Hz during rest and stress imaging, whereas the brief (5-10 frames) high-MI flash impulses to clear the microcirculation were 1.3 (Philips iE33) to 1.9 (Siemens Acuson Sequoia) MI. The flash impulses were given after steady myocardial opacification was reached. Imaging was continued to assess replenishment of contrast after flash destruction of bubbles. Time gain compensation and 2-dimensional gain settings were adjusted to suppress any nonlinear signals from tissue before contrast injection. Digitized images during the myocardial contrast replenishment phase after flash MI impulses were obtained from apical views (4, 2, and 3 chambers) at rest and at maximal stress after the patients had achieved a test end point.
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Stress Protocol
The decision to perform dobutamine or exercise treadmill SE was determined by the referring physician. In either case, patients were instructed to discontinue β-blockers ≥24 hours before the stress test. Patients undergoing exercise stress underwent maximal symptom-limited treadmill exercise according to the Bruce protocol. Patients undergoing dobutamine SE received an intravenous infusion at a starting dose of 5 μg kg −1 min , in 3-to 5-minute stages. Atropine (up to 2.0 mg) was injected in patients not achieving 85% of the predicted maximal heart rate (220−age in years). A 12-lead ECG and blood pressure were recorded at baseline and at the end of each stress level. The end points of the SE were achievement of the target heart rate (85% predicted maximal heart rate), maximal dobutamine or atropine dose, ST-segment elevation ≥2 mm at an interval of 80 m s after the J point in non-Q-wave leads, sustained arrhythmias, severe chest pain, or intolerable adverse effects considered to be because of physical exertion, dobutamine, or atropine.
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Image Interpretation
All studies were analyzed by 2 expert reviewers who had interpreted >500 RTPE studies. The first analysis was considered abnormal by the first reviewer at the time of the study. A second independent read (blinded to angiographic data and clinical history) was performed by a second expert reviewer (F.X.) at a later date after all angiograms. CBF and WM for RTPE were assessed by both readers using a 17-segment model during the replenishment phase of contrast after flash impulses, at baseline, and after peak stress. A study was considered abnormal if an inducible CBF abnormality was observed (independent of WM). CBF was considered normal if myocardial contrast replenishment was observed within 4 s after the flash impulse under resting conditions and within 2 s under stress conditions. Only inducible abnormalities were analyzed for follow-up. Segments were assigned to 1 of the 3 coronary artery territories. 15 Attenuation from contrast or lung interference was considered present if any segment could not be visualized and was not distinguishable from surrounding tissue.
Patients were referred for CA on the basis of the primary reviewer's reading of the study. For outcome purposes, however, a study was considered truly abnormal only if abnormal by both the first and second reviewer. The study was considered negative for outcome purposes if the second reviewer called the study negative after the primary review was read as positive. All CAs were performed within 3 months of the stress test. An experienced interventional cardiologist reviewed all films and defined nonobstructive CAD as those patients with <50% stenosis in a major epicardial vessel or branches. This was further divided into patients with 0% stenoses throughout the entire coronary tree and those with regions of 1% to 49% stenoses in any major vessel or branch.
Patients were then separated into 3 groups based on the results of the primary and second SE readings and subsequent angiography results: positive SE/negative angiogram, patients who had abnormal CBF on the basis of the 2 expert reviews but no significant angiographic disease; positive SE/positive angiogram, were those with abnormal CBF on the basis of 2 expert reviews and significant angiographic disease on subsequent CA; and negative SE/negative angiogram, patients determined as negative (normal CBF) by a second reviewer after an initial positive study by the primary reviewer and who had nonobstructive disease at CA. There were only 19 patients who had abnormal CBF on the primary read but not the second read and who had significant obstructive disease at CA, and therefore, these patients were not included in the outcomes analysis.
Statistical Comparisons
The primary end point of this study was the time from stress echo to death or nonfatal MI. Nonfatal MI was defined as a presentation with chest discomfort or shortness of breath associated with a serial troponin elevation with or without ST-segment elevation in 2 contiguous leads. Death was confirmed by review of chart records. For the analysis of cardiac events in patients who experienced >1 event, only the first hard event was included for the analysis.
Mean, SD, and ranges were determined for continuous variables. Categorical variables were summarized as counts (percent). Patient characteristics were descriptively summarized for each group and compared with χ 2 tests as appropriate. Age was tested for normality using the Wilk-Shapiro test, and the 1-way ANOVA was used to compare the 3 groups. Survival distributions were estimated in patient groups with Kaplan and Meier and compared using the log-rank test. Event-free survival (EFS) was defined as the time from stress test to death or nonfatal MI. Patients without an event were censored at the time of their last follow-up visit. Cox proportional assumptions were verified using the log negative-log survival plot. Multivariable Cox regression was used to determine what clinical and imaging variables were predictors of the primary outcome. Subgroup analysis of stress echo perfusion (positive-positive and positive-negative) was performed to understand perfusion effect in predicting MI or death. The Bonferroni method was used to correct for subanalysis. Finally, the likelihood ratio test was used to assess incremental value of SE perfusion over clinical variables, and then what effect angiography results had over clinical variables plus SE perfusion results. A P <0.05 was considered significant. Statistical analyses were performed using SAS version 9.4 (SAS Institute Inc., Cary, NC).
RESULTS
Study Population
Patient demographics are shown in Table 1 . There were 380 patients who underwent both SE with RTPE and subsequent CA between 2008 and 2013. In this group, 202 (53%) were men and 178 (47%) women. Two hundred thirty-seven (62%) patients underwent dobutamine SE and 143 (38%) patients had exercise SE. Three hundred forty-four (91%) patients had at least 3 risk factors for CAD. Resting regional WM abnormalities were present in 9 (9%) of the negative SE/negative angiogram group, 15 (16%) of the positive SE/negative angiogram group, and 47 (25%) of the positive SE/ positive angiogram groups (P=0.004).
A total of 189 patients (50%) had abnormal CBF at peak stress (confirmed by 2 reviewers) with abnormal angiograms. These abnormal CBFs were derived after the second expert reviewer ruled 18 as negative from 217 that were initially reviewed as positive. WM at peak stress was also abnormal in 183 of these patients (97%). Eighty-three (44%) of these abnormal angiograms were single-vessel CAD and 106 (56%) had multi-vessel CAD. Of the 91 patients with abnormal CBF at peak stress and nonobstructive disease at subsequent angiography (positive SE-negative angiogram), 89 (98%) also had abnormal WM in the same territory.
There were 35 (38%) with no stenoses, and 56 (62%) with <50% nonobstructive lesions. In the negative SEnegative angiogram group, there were 50 (49%) with 0% stenoses and 50 (50%) with <50% nonobstructive lesions. Therefore, the actual incidence in which we observed microvascular angina (abnormal CBF with normal or nonobstructive CAD) was 23%.
Patients in the positive SE-negative angiogram group were more likely to have a positive family history when compared with the negative SE-negative angiogram group (Table 1) and had a similar family history profile as the positive SE-positive angiogram group. Patients in the positive SE-positive angiogram group were more likely to have a history of known CAD and a higher prevalence of hypertension, diabetes mellitus, and smoking when compared with the negative angiography groups. There was a male preponderance in the positive SE-positive angiogram group and a female preponderance in the positive SE-negative angiogram group. Figure 1 displays an example of abnormal perfusion in a 37-year-old man with exertional chest pain who was subsequently found to have no obstructive disease at subsequent angiography (Figure 1, bottom) .
Differences in Clinical Outcomes in the 3 Groups
In all, there were 73 deaths, 16 nonfatal infarctions, and 4 deaths with nonfatal infarctions over the followup period. Median follow-up was 4 years. Death/nonfatal MI rates at a follow-up of 4 years was 26% in the positive SE/negative angiogram patients, 21% in the positive SE/positive angiogram group, and 10% in the negative SE/negative angiogram group. Patients with abnormal CBF but nonobstructive disease at angiography (positive SE/negative angiogram) had a 2-fold higher likelihood of death/nonfatal MI in the 4-year follow-up period compared with a negative SE/negative angiogram group (Figure 2A ). These differences in outcome were still observed when excluding patients whose deaths were presumably from noncardiac causes ( Figure 2B ). However, in this setting, significant differences in outcome only existed between those with positive SE/positive angiogram and negative SE/negative angiogram. In the multivariable analysis of the entire group (Table 2) , age >65 years, smoking history, presence of diabetes mellitus, and presence of hyperlipidemia were significant predictors of death/nonfatal MI. Analysis of EFS with Cox regression demonstrated that death/nonfatal MI rates were higher in the positive SE/ positive CA (hazard ratio, 2.10; CI, 1.02-4.29) and positive SE/negative CA (hazard ratio, 2.02; CI, 0.99-4.31) groups when compared with negative SE/negative CA groups. None of the traditional risk factors other than diabetes mellitus (P=0.046) demonstrated any tendency in predicting all death/nonfatal MI in the positive SE/ negative angiogram group (Table 3 ). Significant multivariable predictors of death/nonfatal MI in the positive SE/positive angiogram group included age (P=0.01) and hyperlipidemia (P=0.04; Table 4 ). The likelihood ratio test showed a nonsignificant trend for perfusion stress echo results over clinical variables listed in Tables 3 and  4 
DISCUSSION
This study indicates that abnormal CBF during demand stress, even when observed in the absence of significant (>50%) obstructive disease, carries with it a significantly increased risk for death or nonfatal myocardial infarction. Both the positive SE/negative angiogram and positive SE/positive angiogram groups had nearly 2-fold higher event rates when compared with the negative SE/negative angiogram group. Although traditional risk factors were predictors of outcome in patients with abnormal CBF and significant disease at angiography, they were not significant predictors in patients with inducible CBF abnormalities without angiographic disease. This indicates that in patients with false-positive stress perfusion studies (when adjudicated by CA), equipoise is required on follow-up and treatment. In these patients, consideration should be given to specific interventions which might improve microvascular function (tighter blood glucose control, 23 ranolazine 24 ) despite this negative angiographic result.
Our results confirm other studies which have demonstrated an abnormal prognostic significance of abnormal WM responses during SE despite angiographically nonobstructive CAD. 1, 25 CBF imaging with an ultrasound contrast infusion has increased the value of SE by improving detection of subendocardial WM abnormalities and by detecting perfusion defects even when transmural WM responses are normal. 15, 26, 27 In patients with known or suspected CAD, CBF imaging with RTPE provides incremental prognostic information over WM analysis during stress testing.
14 Three-year survival was 95% for normal CBF and normal WM, 82% for normal WM and abnormal CBF, and 68% where both parameters were abnormal. These findings were replicated in a cohort of 399 patients >70 years of age. 28 Dawson et al 29 and Gaibazzi et al 30 have demonstrated that CBF assessments during dipyridamole stress provided incremental prognostic data to that provided by ejection fraction and WM analysis in patients with known or suspected CAD. The reduced EFS in patients with perfusion abnormalities during demand stress is similar to the outcomes of patients with abnormalities in microvascular blood flow determined with vasodilator stress positron emission tomography or invasive hemodynamic assessments at CA. [31] [32] [33] EFS was <80% at 4 years in patients with coronary flow reserve <1.6 by myocardial perfusion positron emission tomography despite minimal angiographic evidence of disease. 33 Although it has been assumed that patients with stable angina and nonsignificant or no CAD have favorable outcomes, more recent data have suggested that cardiovascular event rates may be increased in patients with stable angina who demonstrate either no CAD or nonobstructive CAD at angiography. 31 Although intravascular ultrasound studies have demonstrated that a good percentage of these patients have some form of atherosclerotic plaque with positive remodeling, outcomes seem abnormal in both those with no angiographic disease and those with nonobstructive <50% diameter stenosis. In our study, we observed abnormal CBF during demand stress in those with and without nonobstructive plaque at angiography at a frequency rate similar to those without confirmed CBF abnormalities. Furthermore, in the multivariable analysis, the traditional atherosclerotic risk factors that predict outcome in patients with angiographically significant CAD, other than diabetes mellitus, did not predict outcome in those with abnormal CBF and no significant CAD. This would appear to indicate that isolated CBF abnormalities (without significant CAD) may have different pathophysiologic features and risk factor profiles. However, we did observe a tendency for diabetes mellitus to predict outcome in the positive SE/negative angiogram patients. Larger population studies in this patient group may identify whether diabetes mellitus is a risk factor for outcome and the effect of tighter blood glucose control in this patient group. A consistent finding in our study and others has been the higher female to male ratio in patients with isolated CBF abnormalities.
The initial studies using radionuclide imaging and invasive coronary flow reserve measurements to detect microvascular disease demonstrated an increased frequency of abnormal coronary flow reserve and metabolism in patients with nonobstructive disease at angiography. 24 With the development of higher-quality imaging techniques with enhanced spatial resolution, we may identify other regional abnormalities with isolated microvascular disease. For example, we did observe that nearly 16% of patients with positive SE/ negative angiogram had resting WM abnormalities. Although we cannot rule out a prior infarction with spontaneous recanalization or myocarditis playing a role in the resting regional WM abnormality, it may be that the higher resolution and image quality we achieve today with magnetic resonance imaging and low-MI multipulse echocardiography may detect these regional resting defects in patients with microvascular disease.
Furthermore, recent advances in invasive hemodynamic measurements have allowed us to better identify the prevalence of these abnormalities in coronary vessels with normal fractional flow reserve. 34 These studies have demonstrated elevated hyperemic microvascular resistance in over 40% of coronary arteries with normal fractional flow reserve, which is similar to the prevalence we observed in patients with normal or nonobstructive angiograms (48%).
Clinical Implications/Limitations
The EFS in the negative SE/negative angiogram group is lower than what has been observed with negative RTPE studies in the past. 14, 27, 28, 30 To ensure that abnormal stress perfusion studies had a low false-positive rate, we defined an abnormal study as being read abnormal by 2 different independent reviewers with experience in reading >500 studies. No consensus reads were performed. Therefore, this may have resulted in more false-negative studies because of this stricter criterion and may have contributed to a slightly higher event rate in the negative SE/negative angiogram group. However, it gives us the highest specificity for identifying patients with CBF abnormalities. Other possibilities for the higher event rate in this group could be referral bias, in that patients with more compelling symptoms and higher pretest probability were still referred for angiography despite negative SE results. Their lower EFS may also be related to a higher incidence of presumed noncardiac deaths at follow-up ( Figure 2B ).
We classified patients with abnormal stress perfusion and either nonobstructive or no obstructive disease as CBF abnormalities. It is possible that a series of nonobstructive lesions could potentially cause epicardial flow abnormalities during demand stress leading to downstream perfusion/WM abnormalities. However, we observed no difference in the proportion of patients with nonobstructive CAD in the negative SE/ negative angiogram and positive SE/negative angiogram groups.
It is possible that because only 1 interventional cardiologist read the coronary angiograms, there may have been disagreement with regard to the exact severity of the stenoses in the patients with stenoses at or near 50% in severity. Furthermore, during the time period in which we analyzed the data (2008-2013), we were not routinely using either fractional flow reserve or instantaneous flow reserve to assess any intermediate stenosis.
Abnormal demand stress perfusion in the absence of epicardial coronary disease has been correlated with abnormal coronary blood flow reserve measured with invasive hemodynamics. 18, 20 The current study indicates that CBF imaging with RTPE allows these determinations to be made without invasive techniques or additional ionizing radiation. However, this technique requires training, as exemplified by the finding that 101 (25%) studies that were originally read as abnormal were later considered normal by a second expert reviewer. Therefore, current false-positive studies in this field consist of those with true disease and those with true/false-positive abnormalities that are because of attenuation or artifacts.
Further improvements in perfusion imaging methods are required to more accurately identify the patients with isolated microvascular disease. This would include better methods to reduce attenuation and near-field artifacts. By improving the detection of microvascular disease during demand stress imaging, RTPE can better identify a high-risk patient group that should be followed closely irrespective of angiographic findings and prospectively evaluated for new therapeutic strategies. 
